Introduction {#sec1-1}
============

Cognition is the mental process of perception, memory, and information processing that allows a person to have an organized approach for solving problem and making decision.\[[@ref1]\] Any impairment in the abovesaid domains can be termed as cognitive dysfunction. It was first described by Bedford in 1955 as "adverse cerebral effects of anaesthesia" in elderly persons.\[[@ref2]\] The first largest study was conducted by international studies of postoperative cognitive dysfunction (ISPOCD) group who reported that people over 60 years have 26% and 10% incidence of cognitive dysfunction 1 week and 3 months after surgery, respectively.\[[@ref3]\] Initially, it is thought to be a problem in elderly population; but, subsequent studies reported its occurrence in younger populations after surgery and anesthesia. Chung and Assmann\[[@ref4]\] described two cases of young patients who suffered serious traffic accidents shortly after undergoing ambulatory surgery. The effect of anesthesia *per se* on cognitive function depends on the pharmacodynamics and kinetics of the particular agents used. As a rule, the shorter the duration of action of the anesthetic agent, the shorter the duration of cognitive impairment in the immediate postoperative period. Till now, there is no definitive evidence for the assumption that anesthesia itself causes postoperative cognitive dysfunction (POCD).\[[@ref1]\] Studies done to arbitrate the effect of various anesthetic agents on the incidence of POCD differed in their results, where some reporting better cognitive scores with intravenous agent like propofol while others suggesting better cognitive scores with inhalational agents.\[[@ref5][@ref6]\] Exact pathogenesis of POCD is still unclear. It has been postulated that inflammation of the central nervous system (CNS) aggravated by anesthesia and surgery can lead to cognitive deterioration postsurgery.\[[@ref1][@ref7]\] Exposure of anesthesia and surgical insult have been associated with the increase in the brain concentration of interleukin (IL)-6, leading to neuronal apoptosis. This might aggravate the release of the pro-inflammatory cytokine tumor necrosis factor (TNF)-α. S-100β protein is generally found in the CNS and is considered as specific for CNS, so when encountered in the systemic circulation, it might suggest damage to blood--brain barrier\[[@ref8]\] which may result in postoperative cognitive decline.

In a study by Qiao *et al.*\[[@ref5]\] where they compared sevoflurane with propofol for POCD, the authors reported significantly lower cognitive scores in sevoflurane group than in the propofol group in early postoperative day; they also observed that TNF-α and IL-6 levels were significantly higher throughout the first postoperative week in those exposed to sevoflurane than propofol.

We could not find any study comparing the effect of three short acting anesthetic agents -- propofol, desflurane, and sevoflurane on cognitive functions. Hence, we planned to compare the psychometrical effects of propofol, desflurane, or sevoflurane on postoperative cognitive function as anesthetic agents for maintenance of anesthesia in young and middle-aged patients undergoing spine surgery of duration ≥ 2 h under general anesthesia. We also planned to measure plasma S-100β protein concentration, IL-6, and TNF-α concentration to look for the contribution of systemic inflammation to POCD.

Methods {#sec1-2}
=======

This prospective randomized study got institutional ethics committee approval. Written informed consent was obtained from all the patients. All patients underwent mini-mental state examination (MMSE) test which was used as a screening test to decide whether patient could be included in the study. If MMSE score was ≥23, the patient was included in the study. The following patients were excluded from the study -- refusal to consent, cervical spine pathology with upper limb weakness, known psychiatric condition, illiterate, those with significant intraoperative complications, and those who were lost to follow up. Randomization was done by computer-generated random number table, and the random numbers were kept in sequentially numbered opaque envelops. Patients were randomly divided into three groups: Group *P* (Propofol group), Group S (Sevoflurane group, and Group D (Desflurane group). The group allocation is shown in [Flow Chart 1](#F1){ref-type="fig"}.

![Consort diagram](AJNS-14-1095-g001){#F1}

A standard anesthesia protocol was followed in each patient. Anesthesiologist anaesthetizing the patient according to the protocol was not involved in the study. All patients were fasted for 8 h according to the standard NPO guidelines (8 h for any solid food and 2 h for clear water). Patients received oral anxiolytic alprazolam (0.25 mg) night before surgery as premedication. Preinduction monitoring included electrocardiogram, noninvasive blood pressure, pulse oximetry (SpO~2~), and Bi-spectral index (BIS). Baseline hemodynamic parameters were recorded. Fentanyl was administered intravenously in a dose of 2 μg/kg before induction followed by 2 μg/kg/h as infusion for intraoperative analgesia. Patients in all three groups were induced with Propofol (dose titrated to loss of verbal response) and were intubated after injection vecuronium (0.1 mg/kg) when train of four (TOF) count was zero. Lignocaine 1.5 mg/kg was given 90 s before laryngoscopy to prevent the hemodynamic response to laryngoscopy and intubation. The patients were ventilated with oxygen and air (50:50) by anesthesia workstation (Aestiva 5™ 7900, Datex Ohmeda, USA) to keep the ETCO~2~ between 35 and 45 mmHg. Propofol, sevoflurane, or desflurane were used to maintain anesthesia according to the group allocation. The dose of anesthetic agents was titrated to keep the BIS value between the confines of 45 and 55. Intra-arterial cannula was put in all the patients for invasive blood pressure monitoring (IBP). Intraoperatively, patients were monitored for heart rate, IBP, SpO~2,~ neuro-muscular transmission monitoring (NMT), temperature, BIS, and urine output. Hemodynamic parameters, i.e., heart rate and mean arterial pressure were kept between 20% of the baseline value. Toward the end of surgery, fentanyl infusion was discontinued at the beginning of skin closure whereas the maintenance agents were discontinued at the end of skin closure. Toward the end of surgery, local surgical site was infiltrated with bupivacaine 0.25% to provide postoperative analgesia keeping in mind not to exceed dose of bupivacaine more than 2 mg/kg to prevent any toxic side effect. Effect of paralyzing agent was reversed with a combination of neostigmine 50 μg/kg and glycopyrrolate 10 μg/kg when the TOF count was four and TOF percent was 40%. Trachea was extubated when the patients had adequate tidal volume, regular respiration, TOF \>90%, and were able to respond to verbal commands. Patients were followed up for 72-h postsurgery. In postoperative study period, all patients received analgesic drugs paracetamol (1 g) 8 hourly and diclofenac (75 mg) 8 hourly; alternately, morphine (0.05 mg/kg) was given as rescue analgesic to maintain the numeric rating scale score \<4.

Assessment of cognitive function {#sec2-1}
--------------------------------

Each patient was assessed thrice for cognitive function:

In preoperative period to know the baseline values4^th^ day of surgery to assess for early POCDAfter 3 months of surgery and anesthesia exposure to assess delayed POCD.

The battery of cognitive tests to assess cognitive functions included the following {#sec2-2}
-----------------------------------------------------------------------------------

Montreal cognitive assessment (MOCA) to assess visuospatial/executive functions, naming, attention, language, abstraction, recall (delayed) and orientationHopkin\'s verbal learning test (HVLT) to assess verbal memory. Total number of words recalled during three trials were taken for immediate recall, words recalled after 20 min were taken for delayed recall, and number of true positive words recognized from a set of words were taken as a measure for recognitionDigit span test to assess attention. It consisted of three parts: digit forward, digit backward, and total scoreControlled oral word association test to assess fluency. Score consisted of two domains, total number of words and average words.

Level of biomarkers {#sec2-3}
-------------------

The levels of biomarkers: S-100β protein, plasma (IL)-6, and (TNF)-α were assessed. Blood samples were collected in vacutainers before exposure to anesthesia (as baseline values) and 4^th^ day postsurgery (related to early POCD). After allowing the samples to clot at room temperature, the clotted blood in the plain vacutainers were centrifuged at 2000 rpm for 15 min to separate out the serum. Serum was pipetted off into cryovials. All samples were stored at −80°C immediately till analysis. At the end of study, all the samples were analyzed for level of biomarkers using a quantitative ELISA kit (Genxbio Health Sciences Pvt., Ltd.) with precoated antigen wells and a double-antibody sandwich technique.

Data collection {#sec2-4}
---------------

In the preoperative period, data collected were demographic variables (age, sex, ASA status, educational status, and segments of spine involved), battery of cognitive tests to assess the baseline cognitive functions, and the baseline values of the inflammatory biomarkers.

In the intraoperative period, hemodynamics parameters such as heart rate, mean blood pressure, SpO~2~, and end-tidal concentration of carbon dioxide were assessed.

In the postoperative period, battery of cognitive tests was repeated on 4^th^ day of surgery to assess early cognition and after 3 months to assess delayed cognition. Furthermore, levels of inflammatory biomarkers were assessed on 4^th^ day of surgery.

Statistical analysis {#sec2-5}
--------------------

All observations were recorded in a standardized data collection sheet and analyzed statistically. The statistical analysis was carried out using Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, USA, version 22.0 for Windows). Mean were calculated for all quantitative variables. For measures of dispersion, standard deviation or standard error were calculated. Qualitative or categorical variables were described as frequencies and proportions. Appropriate statistical tests were applied for all variables, and *P* \< 0.05 was considered as statistically significant.

Results {#sec1-3}
=======

In all the three groups, the demographic and intraoperative data such as age, sex, ASA grade, presence or absence of any comorbidities, educational status, segment of spine involved, position during surgery, anesthesia duration, and surgery duration were comparable \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic data and intraoperative parameters

                                   Propofol       Desflurane      Sevoflurane    *P*
  -------------------------------- -------------- --------------- -------------- ---------
  Age (years), mean±SD             37.28±10.35    33.56±11.96     38.58±10.64    0.36^α^
  Sex                                                                            
   Male/female (%)                 78/22          78/22           63/37          0.51^β^
  Educational status                                                             
   \<12/\>12 years (%)             44/66          67/33           63/37          0.48^β^
  ASA status                                                                     
   ASA1/ASA2 (%)                   94/6           89/11           94/6           0.74^β^
  Segment of spine involved                                                      
   Single/multi (%)                94/6           83/17           89/11          0.65^β^
  Position                                                                       
   Prone/others (%)                94/6           100/0           89/11          0.56^β^
  Anesthesia time (min), mean±SD   177.22±35.98   172.22±44.82    181.05±26.85   0.76^α^
  Surgical time (min), mean±SD     141.67±35.48   139.44±38.075   142.11±30.29   0.97^α^

*P*≤0.05 was considered significant. ^α^Data analyzed using One-Way ANOVA, ^β^Data analyzed using Pearson Chi-square test. SD -- Standard deviation

Cognitive tests {#sec2-6}
---------------

### Montreal cognitive assessment {#sec3-1}

Preoperative MOCA scores in all groups were comparable (*P* = 0.294) \[Table [2a](#T2){ref-type="table"}, [b](#T3){ref-type="table"} and [Figure 1](#F2){ref-type="fig"}\]. At 4^th^ day, mean MOCA score was slightly higher in all the three groups as compared to baseline values. (Propofol -- 24.89 ± 3.78, desflurane -- 22.72 ± 3.461, and sevoflurane -- 23.58 ± 4.538). However, the improvement was not significant statistically. It was also observed that 3 months following surgery, mean scores were improved significantly from baseline value in all the three groups with greater improvement seen in desflurane and sevoflurane group.

###### 

Intergroup mean montreal cognitive assessment scores

  MOCA (mean±SD)   Propofol     Desflurane   Sevoflurane   *P*
  ---------------- ------------ ------------ ------------- -------
  Baseline         24.72±4.07   22.56±3.98   23.16±4.62    0.294
  Day 4            24.89±3.78   22.72±3.46   23.58±4.53    0.265
  3 months         25.89±4.02   24.56±3.63   25.11±3.88    0.583

Data analyzed using One-way ANOVA. *P*\<0.05 was considered significant. MOCA -- Montreal cognitive assessment, SD -- Standard deviation

###### 

Intragroup difference in mean montreal cognitive assessment scores

                                            Baseline and day 4   *P*    Baseline and 3 months   *P*       Day 4 and 3 months   *P*
  ----------------------------------------- -------------------- ------ ----------------------- --------- -------------------- ---------
  Difference in mean in propofol group      0.16                 1.00   1.16                    0.040\*   1.00                 0.059
  Difference in mean in desflurane group    0.17                 1.00   2.00                    0.000\*   1.83                 0.000\*
  Difference in mean in sevoflurane group   0.42                 0.84   1.94                    0.000\*   1.53                 0.000\*

Data analyzed using repeated measure ANOVA. \**P*≤0.05 was considered significant

![Intragroup difference in mean MOCA scores](AJNS-14-1095-g002){#F2}

### Hopkin\'s verbal learning test {#sec2-7}

Baseline values in total words were comparable in all the three groups \[Table [3a](#T4){ref-type="table"}, [b](#T5){ref-type="table"} and [Figure 2](#F3){ref-type="fig"}\]. We found that the scores improved from baseline to day 4 which was not significant in propofol and desflurane group but was statistically significant in sevoflurane group (*P* = 0.008). Three months following surgery, mean score was improved significantly from baseline value in all the three groups with the highest improvement seen in sevoflurane group. Similarly, delayed recall scores were found to be improved significantly in desflurane and sevoflurane group between baseline and day 4 while assessment at 3 months of surgery revealed significantly higher score in all the three groups. There was no difference in true positive score in any of the groups at any point of time.

###### 

Intergroup Hopkin's verbal learning test

                              Propofol      Desflurane    Sevoflurane   *P*
  --------------------------- ------------- ------------- ------------- -------
  Total HVLT score, mean±SD                                             
   Baseline                   23.11±4.702   20.72±4.725   21.26±5.772   0.345
   Day 4                      24.33±5.594   22.72±5.529   23.84±6.030   0.689
   3 months                   26.06±5.286   24.67±5.325   25.26±6.100   0.757
  Delayed recall, mean±SD                                               
   Baseline                   6.83±2.203    6.39±1.787    6.05±2.718    0.583
   Day 4                      7.50±2.256    7.00±2.058    7.21±2.637    0.813
   3 months                   8.56±2.093    7.83±2.007    7.63±2.712    0.448
  True positives, mean±SD                                               
   Baseline                   10.89±1.079   10.56±1.423   10.62±1.677   0.593
   Day 4                      10.83±1.295   10.67±1.414   10.74±1.558   0.940
   3 months                   11.22±1.114   10.78±1.478   11.05±1.129   0.563

Data analyzed using One-way ANOVA. *P*≤0.05 was considered significant. HVLT -- Hopkin's verbal leaning test; SD -- Standard deviation

###### 

Intragroup differences in Hopkin's verbal learning test

  HVLT                                         Baseline and day 4   *P*       Baseline and 3 months   *P*       Day 4 and 3 months   *P*
  -------------------------------------------- -------------------- --------- ----------------------- --------- -------------------- ---------
  Intragroup difference in propofol group                                                                                            
   Total                                       1.22                 0.275     2.94                    0.004\*   1.72                 0.012\*
   Delayed recall                              0.66                 0.055     1.72                    0.000\*   1.06                 0.002\*
   True positive                               0.06                 1.000     0.33                    0.413     0.39                 0.207
  Intragroup difference in desflurane group                                                                                          
   Total                                       2.00                 0.25      3.94                    0.005\*   1.94                 0.017\*
   Delayed recall                              0.61                 0.035     1.44                    0.000\*   0.83                 0.002\*
   True positive                               0.11                 0.994     0.22                    0.645     0.11                 1.000
  Intragroup difference in sevoflurane group                                                                                         
   Total                                       2.57                 0.008\*   4.00                    0.000\*   1.42                 0.000\*
   Delayed recall                              1.15                 0.003\*   1.57                    0.000\*   0.42                 0.049\*
   True positive                               0.31                 0.412     0.63                    0.072     0.31                 0.332

Data analyzed using repeated Measure ANOVA. \**P*≤0.05 was considered significant. HVLT -- Hopkin's verbal learning test

![Intragroup difference in mean Hopkin\'s verbal learning test scores](AJNS-14-1095-g003){#F3}

### Digit span test {#sec3-2}

We found that mean value of all the three domains in all the groups was comparable at all the time points \[Table [4a](#T6){ref-type="table"}, [b](#T7){ref-type="table"} and [Figure 3](#F4){ref-type="fig"}\]. In digit forward domain, there was slight improvement in score in all the groups between baseline and day 4 which was not significant; but, there was significant improvement in scores between baseline and 3 months in propofol and sevoflurane group (*P* = 0.012 and 0.036, respectively) which was not seen in desflurane group. Similarly, in digit backward domain, there was no significant changes between baseline and day 4 in all the groups, whereas there was significant improvement in scores between baseline and 3 months in all the groups (*P* = 0.010, 0.048, and 0.004, respectively). In total score domain, there was significant improvement in scores between baseline and 3 months in all the groups (0.000, 0.008, and 0.000, respectively).

###### 

Intergroup digit span test

  Digit span test           Propofol      Desflurane    Sevoflurane   *P*
  ------------------------- ------------- ------------- ------------- -------
  Digit forward, mean±SD                                              
   Baseline                 8.17±2.618    7.56±2.093    7.95±2.656    0.755
   Day 4                    8.44±2.455    7.56±2.202    8.11±2.706    0.555
   3 months                 8.72±2.539    7.89±2.166    8.53±2.674    0.574
  Digit backward, mean±SD                                             
   Baseline                 5.56±2.307    3.83±1.790    4.58±2.631    0.085
   Day 4                    5.78±2.264    3.89±1.605    4.95±2.483    0.039
   3 months                 6.06±2.100    4.28±1.638    5.37±2.216    0.034
  Digit total, mean±SD                                                
   Baseline                 13.72±4.586   11.39±3.256   12.53±5.081   0.289
   Day 4                    14.22±4.400   11.44±3.258   13.05±5.071   0.164
   3 months                 14.78±4.333   12.17±3.222   13.89±4.760   0.171

Data analyzed using One-way ANOVA. *P*\<0.05 was considered significant. SD -- Standard deviation

###### 

Intragroup difference in digit span test

  Digit span test                           Baseline and day 4   *P*     Baseline and 1 month   *P*       Day 4 and 1 month   *P*
  ----------------------------------------- -------------------- ------- ---------------------- --------- ------------------- ---------
  Difference in mean in propofol group                                                                                        
   Digit span forward                       0.28                 0.616   0.55                   0.012\*   0.28                0.168
   Digit span backward                      0.22                 0.645   0.50                   0.010\*   0.28                0.168
   Digit total                              0.50                 0.104   1.056                  0.000\*   0.55                0.041
  Difference in mean in desflurane group                                                                                      
   Digit span forward                       0                    1.000   0.33                   0.165     0.33                0.165
   Digit span backward                      0.05                 1.000   0.44                   0.048\*   0.38                0.044\*
   Digit total                              0.05                 1.000   0.78                   0.008\*   0.72                0.010\*
  Difference in mean in sevoflurane group                                                                                     
   Digit span forward                       0.15                 1.000   0.58                   0.036\*   0.42                0.049\*
   Digit span backward                      0.37                 0.207   0.79                   0.004\*   0.42                0.022\*
   Digit total                              0.52                 0.258   1.36                   0.000\*   0.84                0.006\*

Data analyzed using repeated measure ANOVA. \**P*≤0.05 was considered significant

![Intragroup difference in mean digit span scores](AJNS-14-1095-g004){#F4}

### Controlled oral word association test {#sec3-3}

In propofol group, there was slight decrease in scores in both total and average domains between baseline and day 4; but, the difference was not significant whereas in desflurane and sevoflurane group, there was slight improvement which was not significant statistically \[Table [5a](#T8){ref-type="table"}, [b](#T9){ref-type="table"} and [Figure 4](#F5){ref-type="fig"}\]. In all the groups, there was significant improvement in scores between baseline and 3 months with best score observed in sevoflurane group.

###### 

Intergroup mean controlled oral word association test

  COVAS              Propofol       Desflurane     Sevoflurane    *P*
  ------------------ -------------- -------------- -------------- -------
  Total, mean±SD                                                  
   Baseline          32.72±10.824   24.61±12.329   29.05±12.747   0.138
   Day 4             32.28±12.870   27.22±12.614   30.79±15.017   0.521
   3 months          36.06±12.730   30.33±13.092   33.37±15.738   0.474
  Average, mean±SD                                                
   Baseline          10.89±3.579    8.22±4.023     9.63±4.072     0.132
   Day 4             10.72±4.336    9.06±4.022     10.26±4.942    0.515
   3 months          12.06±4.359    10.11±4.324    11.05±5.169    0.460

Data analyzed using one-way ANOVA. \**P*≤0.05 was considered significant. SD -- Standard deviation; COVAS -- Controlled oral word association test

###### 

Intragroup differences in mean controlled oral word association test

  COVAS                                     Baseline and day 4   *P*     Baseline and 3 months   *P*       Day 4 and 3 months   *P*
  ----------------------------------------- -------------------- ------- ----------------------- --------- -------------------- ---------
  Difference in mean in Propofol group                                                                                          
   Total                                    0.44                 1.000   3.33                    0.006\*   3.37                 0.000\*
   Average                                  0.16                 1.000   1.16                    0.007\*   1.33                 0.000\*
  Difference in mean in desflurane group                                                                                        
   Total                                    2.61                 0.249   5.72                    0.006\*   3.11                 0.001\*
   Average                                  0.83                 0.288   1.89                    0.004\*   1.05                 0.001\*
  Difference in mean in sevoflurane group                                                                                       
   Total                                    1.73                 0.204   4.31                    0.001\*   2.57                 0.000\*
   Average                                  0.63                 0.186   1.42                    0.003\*   0.78                 0.000\*

Data analyzed using repeated measure ANOVA. \**P*≤0.05 was considered significant. COVAS -- Controlled oral word association test

![Intergroup mean controlled oral word association test](AJNS-14-1095-g005){#F5}

Serum biomarkers {#sec2-8}
----------------

### S100b {#sec3-4}

In all the three groups, there was slight increase in the values of biomarkers levels between baseline and day 4 which was not significant (*P* = 0.705, 0.682, and 0.892, respectively) \[[Table 6](#T10){ref-type="table"} and [Figure 5](#F6){ref-type="fig"}\].

###### 

Serum biomarkers

  Mean S-100β value                     Baseline (ng/L)        Day 4 (ng/L)        *P*
  ------------------------------------- ---------------------- ------------------- ---------
  Propofol                              569.55±416             586.44±443          0.705
  Desflurane                            605.87±682             594.59±698          0.682
  Sevoflurane                           521.63±554             524.47±558          0.892
                                                                                   
  **Mean interleukin 6 value**          **Baseline (pg/ml)**   **Day 4 (ng/L)**    ***P***
                                                                                   
  Propofol                              21.67±41.56            24.50±38.07         0.279
  Desflurane                            30.61±63.29            33.44±63.83         0.074
  Sevoflurane                           26.32±38.04            28.95±48.36         0.606
                                                                                   
  **Mean tumor necrosis factor alfa**   **Baseline (pg/ml)**   **Day 4 (pg/ml)**   ***P***
                                                                                   
  Propofol                              20.94±15.22            22.28±13.16         0.566
  Desflurane                            27.28±18.06            30.06±18.82         0.329
  Sevoflurane                           26.16±27.49            27.95±28.47         0.594

Data analyzed using Paired *t*-test. \**P*≤0.05 was considered significant

![Mean serum biomarker](AJNS-14-1095-g006){#F6}

### Interleukin 6 {#sec3-5}

In all the three groups, there was slight increase in the values of biomarkers levels between baseline and day 4 which was not significant (*P* = 0.279, 0.074, and 0.606, respectively) \[[Table 6](#T10){ref-type="table"} and [Figure 5](#F6){ref-type="fig"}\].

### Tumor necrosis factor alfa {#sec3-6}

In all the three groups, there was slight increase in the values of biomarkers levels between baseline and day 4 which was not significant (*P* = 0.566, 0.329, and 0.594, respectively) \[[Table 6](#T10){ref-type="table"} and [Figure 5](#F6){ref-type="fig"}\].

Discussion {#sec1-4}
==========

Cognitive deterioration is a widely debated complication after surgery and exposure to anesthetic agents and POCD after surgery, and anesthesia is considered to affect mostly the elderly patients undergoing longer duration surgery. Patients posted for cardiac surgery under cardiopulmonary bypass also found to have POCD.\[[@ref9]\]

Most of the previous studies were done in elderly patients undergoing surgery; but, there are very few studies which have been done in relatively younger age group. Two major studies in younger age group patients were done by ISPOCD 2 group\[[@ref10]\] and by Dokkedal *et al.*\[[@ref11]\] In ISPOCD 2, the authors reported that the incidence of cognitive dysfunction at 7^th^ postoperative day was 19.2% among patients and 4.0% among controls while at 3 months after surgery, 6.2% had POCD. In another large study by Dokkedal *et al.*,\[[@ref11]\] the authors tried to find the relationship between surgery and anesthesia and the POCD in 8503 twins in middle-aged and elderly age group and could not find any significant difference in cognitive scores in middle-aged patients over controls. Moreover, they found higher cognitive scores in patients with hip and knee arthroplasty. Hence, whether cognitive functions do get impaired after surgery and exposure to anesthesia in younger patients still remains a question to be answered.

In our study, we performed MOCA test to assess the following domains of cognition - visuospatial/executive functions, naming, attention, language, abstraction, recall (delayed), and orientation. Furthermore, we assessed verbal memory, attention, and fluency in detail with other appropriate neuropsychological tests as these domains are thought to be affected in postoperative periods. In our analysis, we did not find any cognitive decline in both early and late postoperative period; rather, in our patients, there was slight improvement in cognitive scores in early postoperative period and significant improvement in scores in late postoperative period in all the groups.

Although there are various studies on POCD, it is difficult to compare our results with those studies as majority of the studies were done in elderly patients, and the methodology and group allocations are quite different in all the studies. The results can be explained by the fact that majority of patients with spine disorders present to hospital with pain due to nerve compression. This might have an impact on the cognitive functions before surgery, and successful relief of pain postsurgery might have resulted in improvement of cognitive functions. Studies have shown that preoperative and postoperative pain can affect cognition.\[[@ref12]\] Furthermore, the cognitive assessment was done 1 day before surgery, which might falsely have led to lower values due to preoperative anxiety. Patients are usually scared about pain, awareness during surgery, and for unknown life-threatening complications during and after surgery, and the unfamiliar and uncertain environment might have affected their cooperation and concentration to perform these tests. Studies also support the fact that anxiety can affect the cognition.\[[@ref13]\] Moreover, studies have reported higher anxiety scores in younger age group than in elderly groups.\[[@ref13]\] Similar to our results, Dokkedal *et al.*\[[@ref11]\] also could not find any significant difference in cognitive scores in middle-aged patients over controls, and they also found higher cognitive scores in patients with hip and knee arthroplasty in postoperative period. They concluded by explaining that reduced pain and increased mobility after successful joint replacements and subsequent improvement in level of functioning might have resulted in higher cognitive scores in postoperative period. Hence, they emphasized on the fact that underlying disease could have affected the cognition in postoperative period rather than exposure to anesthesia and surgery. Fischer *et al.*\[[@ref14]\] also reported that there was no association between number of general anesthesia and cognitive deficiency in elderly patients aged 75 years or older. Similarly, Monk *et al.*\[[@ref15]\] in their study reported that the incidence of cognitive dysfunction was similar between age-matched controls and young and middle-aged patients but was significantly higher in the elderly patients when compared to elderly controls.

Qiao *et al.*\[[@ref5]\] used MOCA to compare sevoflurane with propofol for POCD and reported that the scores were significantly poor in sevoflurane group than in the propofol group on the 1^st^, 3^rd^, and 7^th^ postoperative days; but, contrary to our study, they assessed cognition in elderly patients in their study, so their results cannot be extrapolated to our study.

Our results were different with respect to results reported by ISPOCD 2 group who have reported incidence of cognitive dysfunction at 7^th^ postoperative day as 19.2% among patients, and after 3 months, the incidence was 6.2% in patients which was not significant.\[[@ref10]\] This difference may be due to metacentric nature and inclusion of all types of surgeries. They also acknowledged the fact that due to multicenter assessment, the resources and practice of assessment of the cognitive testing might have varied with center, with some centers reporting higher incidence of POCD. In our study, we included patients who underwent the surgery for spine diseases; so, our study group, type of anesthesia, and surgery were uniform.

Overall, better HVLT scores in our study postoperatively can be explained by confounding factors such as preexisting pain and anxiety which could have affected our preoperative values. The improvement on verbal tasks can also be likely due to practice effects as the tests were repeated in short intervals.\[[@ref16]\] Our reported results were similar to findings reported by Ancelin *et al.*\[[@ref17]\] in their study done in old individuals undergoing elective orthopedic surgery, in which they found significant recovery in verbal cognitive tasks including immediate and delayed verbal recall in the postoperative periods.

Our results also demonstrated better scores with sevoflurane anesthesia. Goswami *et al.*\[[@ref6]\] in their study compared two anesthetic agents -- propofol and sevoflurane on cognitive function in the postoperative period and reported that cognitive functions were better in sevoflurane group in the early postoperative period. In another study, Schoen *et al.*\[[@ref18]\] mentioned significantly better early memory cognitive functions in sevoflurane compared to propofol in the patients undergoing CABG similar to our study.

Our scores for attention and fluency were found to improve over time in the postoperative period. However, Ancelin *et al.*\[[@ref17]\] did not find any difference in attention and fluency scores in patients in postoperative period. This subtle difference might be attributed to the fact that they did their study in elderly population while our study was done in young and middle-aged patients. In spite of methodological differences, our results were similar to few studies which described nonexistence of cognitive decline in younger and middle age group. Mashour *et al.*\[[@ref19]\] in their review had pointed out that when patients recover from the insult of surgery, they might revert to their predicted cognitive paths, based on their preoperative trajectories. This could occur when surgery results in decreased pain, decreased inflammation, increased cerebral blood flow, and enhanced ability to function in daily life. Similarly, Seminowicz *et al.*\[[@ref20]\] in their study proved that with effective management of chronic low back pain in humans, there is reversal of abnormal brain anatomy and function. They found that with treatment, there was increase in cortical thickness in the left dorsolateral prefrontal cortex, which was found to be thinner before treatment compared with controls. Increased dorsolateral prefrontal cortex thickness correlated with the reduction of both pain and physical disability. Similar findings were also reported by Sato *et al.*\[[@ref21]\] in which they reported that there was gain in cerebral white matter fractional anisotropy on diffusion tensor magnetic resonance imaging in postoperative period which correlated with cognitive improvement after surgery for uncomplicated carotid endarterectomy.

Role of inflammatory biomarkers {#sec2-9}
-------------------------------

S-100β is predominantly found in astrocytes, glial, and Schwann cells in the CNS; so, any rise in its value may reflect neuroinflammation and injury which we may be related to any cognitive decline in the postoperative period.\[[@ref22]\] TNF-α is released by monocyte and macrophages which in turn promotes the release of other inflammatory mediators and pro-inflammatory cytokines such as IL-6, thus starting the inflammatory cascade reaction.\[[@ref23]\] The role of IL-6 was discovered as a regulator for synapse formation, and local high concentration was found to inhibit synaptic function.\[[@ref24]\] Administration of a neutralizing protein for IL-6 considerably improves long-term potentiation (LTP) and memory in rats. The impact of IL-6 on the LTP, and its inhibitory consequences on learning and memory formation describes its role in development of POCD.\[[@ref25]\] Hence, we decided to assess levels of S-100β, IL-6, and TNF a as surrogate biomarker of cognitive function. Our study revealed that there was slight increase in the levels of all the biomarkers in early postoperative period which was not statistically significant. We could not find any association with cognitive functions. The slight increase in the concentration of biomarkers in our study might be due to the disease and surgery itself. Various studies have varied in their results with respect to use of inflammatory biomarkers as test for cognitive functions. Qiao *et al.*\[[@ref5]\] in their study had reported that there was significant increase in the concentration of S-100β, IL-6, and TNF a in postoperative period in sevoflurane group as compared to propofol group which correlated with their higher incidence of POCD in sevoflurane group. This might be due to the fact that they had done their study in elderly patients who are posted for surgery for colorectal cancer. The age group and the nature of disease itself might have resulted in higher concentration in postoperative period. Similarly, Peng *et al.*\[[@ref26]\] in their meta-analysis on the role of peripheral inflammatory marker on POCD stated that high concentrations of S-100β and IL-6 are definitely correlated with the POCD, but also acknowledged that there might be some sources of heterogeneity, including assay methodology, age, gender, and medical comorbidity which could have affected the results. Moreover, most studies in their meta-analysis had reported very large standard deviations suggesting substantial unexplained interindividual variations. Micha *et al.*\[[@ref27]\] could not find any correlation between inflammatory biomarkers and POCD. Similarly, Saleem *et al.*\[[@ref28]\] did a meta-analysis and their findings did not support the use of elevations in peripheral inflammatory factors in mild cognitive impairment; similarly, we also did not find any correlation of inflammatory biomarkers with cognitive scores.

Limitations {#sec2-10}
-----------

In our study, we did not have age-matched controls who were not exposed to anesthesia and surgery, which could have given a better idea about the degree of change in cognitive functions. Assessments of cognitive functions were done 12--24 h before surgery; so, our baseline values might have been affected by confounding factors such as pain and preoperative anxiety. Baseline cognitive tests should have been done at least a week before surgery which was not possible in our hospital settings as patients are admitted in our hospital only 24--48 h before surgery. Other important consideration was the practice effect on cognitive scores which should be taken seriously. The cognitive tests should be done in calm and quiet room to avoid any disturbance so that patients could concentrate and cooperate during the test, which was not possible in all the cases.

Conclusion {#sec1-5}
==========

In young and middle-aged persons undergoing surgery for spine disorders, there is no effect of commonly used shorter acting anesthetic agents on the postoperative cognitive functions. Furthermore, there is no association of inflammatory markers with respect to the patient\'s cognitive status.
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